Harnessing OLIG2 function in tumorigenicity and plasticity to target malignant gliomas

References

• Jansen M, Yip S, Louis DN. Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers. Lancet Neurol. 2010;9:717-26. doi:10.1016/S1474-4422(10)70105-8. PMID:20610347
   PubMed Web of Science ®Google Scholar
• Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, et al. The somatic genomic landscape of glioblastoma. Cell. 2013;155:462-77. doi:10.1016/j.cell.2013.09.034. PMID:24120142
   PubMed Web of Science ®Google Scholar
• Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321:1807-12. doi:10.1126/science.1164382. PMID:18772396
   PubMed Web of Science ®Google Scholar
• Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344:1396-401. doi:10.1126/science.1254257. PMID:24925914
   PubMed Web of Science ®Google Scholar
• Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H, et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature. 2010;463:318-25. doi:10.1038/nature08712. PMID:20032975
   PubMed Web of Science ®Google Scholar
• Friedmann-Morvinski D, Bushong EA, Ke E, Soda Y, Marumoto T, Singer O, Ellisman MH, Verma IM. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science. 2012;338:1080-4. doi:10.1126/science.1226929. PMID:23087000
   PubMed Web of Science ®Google Scholar
• Liu C, Sage JC, Miller MR, Verhaak RG, Hippenmeyer S, Vogel H, Foreman O, Bronson RT, Nishiyama A, Luo L, et al. Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell. 2011;146:209-21. doi:10.1016/j.cell.2011.06.014. PMID:21737130
   PubMed Web of Science ®Google Scholar
• Zhu Y, Guignard F, Zhao D, Liu L, Burns DK, Mason RP, Messing A, Parada LF. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell. 2005;8:119-30. doi:10.1016/j.ccr.2005.07.004. PMID:16098465
   PubMed Web of Science ®Google Scholar
• Alcantara Llaguno S, Chen J, Kwon CH, Jackson EL, Li Y, Burns DK, Alvarez-Buylla A, Parada LF. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell. 2009;15:45-56. doi:10.1016/j.ccr.2008.12.006. PMID:19111880
   PubMed Web of Science ®Google Scholar
• Persson AI, Petritsch C, Swartling FJ, Itsara M, Sim FJ, Auvergne R, Goldenberg DD, Vandenberg SR, Nguyen KN, Yakovenko S, et al. Non-stem cell origin for oligodendroglioma. Cancer Cell. 2010;18:669-82. doi:10.1016/j.ccr.2010.10.033. PMID:21156288
   PubMed Web of Science ®Google Scholar
• Galvao RP, Kasina A, McNeill RS, Harbin JE, Foreman O, Verhaak RGW, Nishiyama A, Miller CR, Zong H. Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process. Proceedings of the National Academy of Sciences of the United States of America. 2014;111:E4214-E23. doi:10.1073/pnas.1414389111. PMID:25246577
   PubMed Web of Science ®Google Scholar
• Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17:98-110. doi:10.1016/j.ccr.2009.12.020. PMID:20129251
   PubMed Web of Science ®Google Scholar
• Hayden EC. Genomics boosts brain-cancer work. Nature. 2010;463:278. doi:10.1038/463278a. PMID:20090720
   PubMed Web of Science ®Google Scholar
• Isella C, Terrasi A, Bellomo SE, Petti C, Galatola G, Muratore A, Mellano A, Senetta R, Cassenti A, Sonetto C, et al. Stromal contribution to the colorectal cancer transcriptome. Nat Genet. 2015;47:312-9. doi:10.1038/ng.3224. PMID:25706627
   PubMed Web of Science ®Google Scholar
• Martinez E, Yoshihara K, Kim H, Mills GM, Trevino V, Verhaak RG. Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects. Oncogene. 2015;34:2732-40. doi:10.1038/onc.2014.216. PMID:25088195
   PubMed Web of Science ®Google Scholar
• Calon A, Lonardo E, Berenguer-Llergo A, Espinet E, Hernando-Momblona X, Iglesias M, Sevillano M, Palomo-Ponce S, Tauriello DV, Byrom D, et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat Genet. 2015;47:320-9. doi:10.1038/ng.3225. PMID:25706628
   PubMed Web of Science ®Google Scholar
• Kim H, Verhaak RG. Transcriptional mimicry by tumor-associated stroma. Nat Genet. 2015;47:307-9. doi:10.1038/ng.3255. PMID:25814306
   PubMed Web of Science ®Google Scholar
• Eidel O, Burth S, Neumann JO, Kieslich PJ, Sahm F, Jungk C, Kickingereder P, Bickelhaupt S, Mundiyanapurath S, Baumer P, et al. Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology. PLoS One. 2017;12:e0169292. doi:10.1371/journal.pone.0169292. PMID:28103256
   PubMed Web of Science ®Google Scholar
• Bhat KP, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James JD, Goodman LD, et al. Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma. Cancer Cell. 2013;24:331-46. doi:10.1016/j.ccr.2013.08.001. PMID:23993863
   PubMed Web of Science ®Google Scholar
• Meyer M, Reimand J, Lan X, Head R, Zhu X, Kushida M, Bayani J, Pressey JC, Lionel AC, Clarke ID, et al. Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity. Proc Natl Acad Sci U S A. 2015;112:851-6. doi:10.1073/pnas.1320611111. PMID:25561528
   PubMed Web of Science ®Google Scholar
• Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, Rowitch DH. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell. 2002;109:75-86. doi:10.1016/S0092-8674(02)00678-5. PMID:11955448
   PubMed Web of Science ®Google Scholar
• Zhou Q, Anderson DJ. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell. 2002;109:61-73. doi:10.1016/S0092-8674(02)00677-3. PMID:11955447
   PubMed Web of Science ®Google Scholar
• Takebayashi H, Nabeshima Y, Yoshida S, Chisaka O, Ikenaka K, Nabeshima Y. The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr Biol. 2002;12:1157-63. doi:10.1016/S0960-9822(02)00926-0. PMID:12121626
   PubMed Web of Science ®Google Scholar
• Zhu X, Zuo H, Maher BJ, Serwanski DR, LoTurco JJ, Lu QR, Nishiyama A. Olig2-dependent developmental fate switch of NG2 cells. Development. 2012;139:2299-307. doi:10.1242/dev.078873. PMID:22627280
   PubMed Web of Science ®Google Scholar
• Zhang L, He X, Liu L, Jiang M, Zhao C, Wang H, He D, Zheng T, Zhou X, Hassan A, et al. Hdac3 Interaction with p300 Histone Acetyltransferase Regulates the Oligodendrocyte and Astrocyte Lineage Fate Switch. Dev Cell. 2016;36:316-30. doi:10.1016/j.devcel.2016.01.002. PMID:26859354
   PubMed Web of Science ®Google Scholar
• Lu QR, Park JK, Noll E, Chan JA, Alberta J, Yuk D, Alzamora MG, Louis DN, Stiles CD, Rowitch DH, et al. Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc Natl Acad Sci U S A. 2001;98:10851-6. doi:10.1073/pnas.181340798. PMID:11526205
   PubMed Web of Science ®Google Scholar
• Ligon KL, Alberta JA, Kho AT, Weiss J, Kwaan MR, Nutt CL, Louis DN, Stiles CD, Rowitch DH. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol. 2004;63:499-509. doi:10.1093/jnen/63.5.499. PMID:15198128
   PubMed Web of Science ®Google Scholar
• Lu F, Chen Y, Zhao C, Wang H, He D, Xu L, Wang J, He X, Deng Y, Lu EE, et al. Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma. Cancer Cell. 2016;29:669-83. doi:10.1016/j.ccell.2016.03.027. PMID:27165742
   PubMed Web of Science ®Google Scholar
• Ligon KL, Huillard E, Mehta S, Kesari S, Liu H, Alberta JA, Bachoo RM, Kane M, Louis DN, Depinho RA, et al. Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron. 2007;53:503-17. doi:10.1016/j.neuron.2007.01.009. PMID:17296553
   PubMed Web of Science ®Google Scholar
• Singh SK, Fiorelli R, Kupp R, Rajan S, Szeto E, Lo Cascio C, Maire CL, Sun Y, Alberta JA, Eschbacher JM, et al. Post-translational Modifications of OLIG2 Regulate Glioma Invasion through the TGF-beta Pathway. Cell Rep. 2016;16:950-66. doi:10.1016/j.celrep.2016.06.045. PMID:27396340
   PubMed Web of Science ®Google Scholar
• Kupp R, Shtayer L, Tien AC, Szeto E, Sanai N, Rowitch DH, Mehta S. Lineage-Restricted OLIG2-RTK Signaling Governs the Molecular Subtype of Glioma Stem-like Cells. Cell Rep. 2016;16:2838-45. doi:10.1016/j.celrep.2016.08.040. PMID:27626655
   PubMed Web of Science ®Google Scholar
• Suva ML, Rheinbay E, Gillespie SM, Patel AP, Wakimoto H, Rabkin SD, Riggi N, Chi AS, Cahill DP, Nahed BV, et al. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell. 2014;157:580-94. doi:10.1016/j.cell.2014.02.030. PMID:24726434
   PubMed Web of Science ®Google Scholar
• Otero JJ, Rowitch D, Vandenberg S. OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms. J Neurooncol. 2011;104:423-38. doi:10.1007/s11060-010-0509-x. PMID:21193945
   PubMed Web of Science ®Google Scholar
• Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9:157-73. doi:10.1016/j.ccr.2006.02.019. PMID:16530701
   PubMed Web of Science ®Google Scholar
• Alcantara Llaguno SR, Wang Z, Sun D, Chen J, Xu J, Kim E, Hatanpaa KJ, Raisanen JM, Burns DK, Johnson JE, et al. Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes. Cancer Cell. 2015;28:429-40. doi:10.1016/j.ccell.2015.09.007. PMID:26461091
   PubMed Web of Science ®Google Scholar
• Lei L, Sonabend AM, Guarnieri P, Soderquist C, Ludwig T, Rosenfeld S, Bruce JN, Canoll P. Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype. PLoS One. 2011;6:e20041. doi:10.1371/journal.pone.0020041. PMID:21625383
   PubMed Web of Science ®Google Scholar
• Sonabend AM, Bansal M, Guarnieri P, Lei L, Amendolara B, Soderquist C, Leung R, Yun J, Kennedy B, Sisti J, et al. The transcriptional regulatory network of proneural glioma determines the genetic alterations selected during tumor progression. Cancer Res. 2014;74:1440-51. doi:10.1158/0008-5472.CAN-13-2150. PMID:24390738
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, Parada LF. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488:522-6. doi:10.1038/nature11287. PMID:22854781
   PubMed Web of Science ®Google Scholar
• Mehta S, Huillard E, Kesari S, Maire CL, Golebiowski D, Harrington EP, Alberta JA, Kane MF, Theisen M, Ligon KL, et al. The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma. Cancer Cell. 2011;19:359-71. doi:10.1016/j.ccr.2011.01.035. PMID:21397859
   PubMed Web of Science ®Google Scholar
• Yu Y, Chen Y, Kim B, Wang H, Zhao C, He X, Liu L, Liu W, Wu LM, Mao M, et al. Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation. Cell. 2013;152:248-61. doi:10.1016/j.cell.2012.12.006. PMID:23332759
   PubMed Web of Science ®Google Scholar
• Ozawa T, Riester M, Cheng YK, Huse JT, Squatrito M, Helmy K, Charles N, Michor F, Holland EC. Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma. Cancer Cell. 2014;26:288-300. doi:10.1016/j.ccr.2014.06.005. PMID:25117714
   PubMed Web of Science ®Google Scholar
• Cai J, Chen Y, Cai WH, Hurlock EC, Wu H, Kernie SG, Parada LF, Lu QR. A crucial role for Olig2 in white matter astrocyte development. Development. 2007;134:1887-99. doi:10.1242/dev.02847. PMID:17428828
   PubMed Web of Science ®Google Scholar
• Deneen B, Ho R, Lukaszewicz A, Hochstim CJ, Gronostajski RM, Anderson DJ. The transcription factor NFIA controls the onset of gliogenesis in the developing spinal cord. Neuron. 2006;52:953-68. doi:10.1016/j.neuron.2006.11.019. PMID:17178400
   PubMed Web of Science ®Google Scholar
• Glasgow SM, Zhu W, Stolt CC, Huang TW, Chen F, LoTurco JJ, Neul JL, Wegner M, Mohila C, Deneen B. Mutual antagonism between Sox10 and NFIA regulates diversification of glial lineages and glioma subtypes. Nat Neurosci. 2014;17:1322-9. doi:10.1038/nn.3790. PMID:25151262
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD, Vogel H, Steinberg GK, Edwards MS, Li G, et al. Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse. Neuron. 2015
   Web of Science ®Google Scholar
• Aguirre A, Dupree JL, Mangin JM, Gallo V. A functional role for EGFR signaling in myelination and remyelination. Nat Neurosci. 2007;10:990-1002. doi:10.1038/nn1938. PMID:17618276
   PubMed Web of Science ®Google Scholar
• Aguirre A, Rubio ME, Gallo V. Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal. Nature. 2010;467:323-7. doi:10.1038/nature09347. PMID:20844536
   PubMed Web of Science ®Google Scholar
• Gonzalez-Perez O, Romero-Rodriguez R, Soriano-Navarro M, Garcia-Verdugo JM, Alvarez-Buylla A. Epidermal growth factor induces the progeny of subventricular zone type B cells to migrate and differentiate into oligodendrocytes. Stem Cells. 2009;27:2032-43. doi:10.1002/stem.119. PMID:19544429
   PubMed Web of Science ®Google Scholar
• Sugiarto S, Persson AI, Munoz EG, Waldhuber M, Lamagna C, Andor N, Hanecker P, Ayers-Ringler J, Phillips J, Siu J, et al. Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell. 2011;20:328-40. doi:10.1016/j.ccr.2011.08.011. PMID:21907924
   PubMed Web of Science ®Google Scholar
• Ivkovic S, Canoll P, Goldman JE. Constitutive EGFR signaling in oligodendrocyte progenitors leads to diffuse hyperplasia in postnatal white matter. J Neurosci. 2008;28:914-22. doi:10.1523/JNEUROSCI.4327-07.2008. PMID:18216199
   PubMed Web of Science ®Google Scholar
• Singh DK, Kollipara RK, Vemireddy V, Yang XL, Sun Y, Regmi N, Klingler S, Hatanpaa KJ, Raisanen J, Cho SK, et al. Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma. Cell Rep. 2017;18:961-76. doi:10.1016/j.celrep.2016.12.064. PMID:28122245
   PubMed Web of Science ®Google Scholar
• Caren H, Stricker SH, Bulstrode H, Gagrica S, Johnstone E, Bartlett TE, Feber A, Wilson G, Teschendorff AE, Bertone P, et al. Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle Arrest. Stem Cell Reports. 2015;5:829-42. doi:10.1016/j.stemcr.2015.09.014. PMID:26607953
   PubMed Web of Science ®Google Scholar
• Tome-Garcia J, Tejero R, Nudelman G, Yong RL, Sebra R, Wang H, Fowkes M, Magid M, Walsh M, Silva-Vargas V, et al. Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties. Stem Cell Reports. 2017;8:1421-9. doi:10.1016/j.stemcr.2017.03.019. PMID:28434940
   PubMed Web of Science ®Google Scholar
• Tirosh I, Venteicher AS, Hebert C, Escalante LE, Patel AP, Yizhak K, Fisher JM, Rodman C, Mount C, Filbin MG, et al. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature. 2016;539:309-13. doi:10.1038/nature20123. PMID:27806376
   PubMed Web of Science ®Google Scholar
• Mateo JL, van den Berg DL, Haeussler M, Drechsel D, Gaber ZB, Castro DS, Robson P, Crawford GE, Flicek P, Ettwiller L, et al. Characterization of the neural stem cell gene regulatory network identifies OLIG2 as a multifunctional regulator of self-renewal. Genome Res. 2015;25:41-56. doi:10.1101/gr.173435.114. PMID:25294244
   PubMed Web of Science ®Google Scholar
• Olar A, Aldape KD. Using the molecular classification of glioblastoma to inform personalized treatment. J Pathol. 2014;232:165-77. doi:10.1002/path.4282. PMID:24114756
   PubMed Web of Science ®Google Scholar
• Piao Y, Liang J, Holmes L, Henry V, Sulman E, de Groot JF. Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition. Clin Cancer Res. 2013;19:4392-403. doi:10.1158/1078-0432.CCR-12-1557. PMID:23804423
   PubMed Web of Science ®Google Scholar
• Sun Y, Meijer DH, Alberta JA, Mehta S, Kane MF, Tien AC, Fu H, Petryniak MA, Potter GB, Liu Z, et al. Phosphorylation state of Olig2 regulates proliferation of neural progenitors. Neuron. 2011;69:906-17. doi:10.1016/j.neuron.2011.02.005. PMID:21382551
   PubMed Web of Science ®Google Scholar
• Zhou J, Tien AC, Alberta JA, Ficarro SB, Griveau A, Sun Y, Deshpande JS, Card JD, Morgan-Smith M, Michowski W, et al. A Sequentially Priming Phosphorylation Cascade Activates the Gliomagenic Transcription Factor Olig2. Cell Rep. 2017;18:3167-77. doi:10.1016/j.celrep.2017.03.003. PMID:28355568
   PubMed Web of Science ®Google Scholar